Reata Pharmaceuticals Inc (NASDAQ:RETA)

Delayed Data
As of Dec 03
 -7.08 / -8.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 230.00, with a high estimate of 282.00 and a low estimate of 175.00. The median estimate represents a +191.69% increase from the last price of 78.85.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.87%
Growthannually -11.29%


Growthquarterly -77.99%
Growthannually 35.50%
Key to the earnings and sales forecast charts.